Skip to main navigation Skip to search Skip to main content

A somatic multiple myeloma mutation unravels a mechanism of oligomerization-mediated product inhibition in GGPPS

  • Ruba Yehia
  • , Jasmína Mária Portašiková
  • , Rut Mor Yosef
  • , Benny Da'adoosh
  • , Alan Kádek
  • , Petr Man
  • , Moshe Giladi*
  • , Yoni Haitin*
  • *Corresponding author for this work
  • Czech Academy of Sciences
  • Charles University
  • Tel Aviv Sourasky Medical Center

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Protein prenylation plays a critical role in regulating the cellular localization of small GTPases and is essential for multiple myeloma (MM) pathology. Geranylgeranyl diphosphate synthase (GGPPS), producing a key prenylation moiety, exists in a dimeric or hexameric form, depending on the species. However, the functional significance of this oligomerization remains unclear. Using crystallography, mass spectrometry, and fluorescence spectroscopy, we show that the GGPPSR235C mutant—found in the widely studied MM cell line RPMI-8226—exhibits weakened inter-dimer interactions, reduced hexamer stability, and increased apparent substrate affinity and product release kinetics. These effects are even more pronounced in a dimeric mutant, GGPPSY246D, demonstrating that interdimer interactions within the hexamer help stabilize a lid region over the active site, thereby stabilizing product binding in an inhibitory conformation. Together, these findings reveal that hexamerization regulates GGPPS activity through product inhibition and underscore the importance of cell line selection and characterization in drug discovery efforts.

Original languageEnglish
Pages (from-to)5802-5817
Number of pages16
JournalFEBS Journal
Volume292
Issue number21
DOIs
StatePublished - Nov 2025

Funding

FundersFunder number
Kahn Foundation
Tel Aviv Sourasky Medical Center
European Regional Development FundCZ.02.1.01/0.0/0.0/18_046/0015974
European Commission101090276
Ministerstvo Školství, Mládeže a TělovýchovyCZ.02.01.01/00/22_008/0004624
National Science Foundation2023190
Israel Cancer Research Fund19202, 1289067
Israel Science Foundation1653/21
CIISBLM2023042
Israel Cancer Association20230029

    Keywords

    • GGPPS
    • multiple myeloma
    • oligomerization
    • structure–function

    Fingerprint

    Dive into the research topics of 'A somatic multiple myeloma mutation unravels a mechanism of oligomerization-mediated product inhibition in GGPPS'. Together they form a unique fingerprint.

    Cite this